Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.07.2022 | Case report

Amrubicin

Decrease in the neutrophil count and drug tolerance: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ogikubo M, et al. Postoperative Relapse of Combined Large-Cell Neuroendocrine Carcinoma of the Lung with a Remarkable Transient Response to Amrubicin Monotherapy in an Elderly Patient - A Case Report. [Japanese]. Gan to Kagaku Ryoho 48: 681-683, No. 5, May 2021. Available from: URL: https://www.pieronline.jp/content/article/0385-0684/48050/681 [Japanese; summarised from an english abstract] Ogikubo M, et al. Postoperative Relapse of Combined Large-Cell Neuroendocrine Carcinoma of the Lung with a Remarkable Transient Response to Amrubicin Monotherapy in an Elderly Patient - A Case Report. [Japanese]. Gan to Kagaku Ryoho 48: 681-683, No. 5, May 2021. Available from: URL: https://​www.​pieronline.​jp/​content/​article/​0385-0684/​48050/​681 [Japanese; summarised from an english abstract]
Metadaten
Titel
Amrubicin
Decrease in the neutrophil count and drug tolerance: case report
Publikationsdatum
01.07.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-19065-6

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Multiple drugs

Case report

Bencyclane

Case report

Antineoplastics

Case report

Plasma